TrialScandinavian journal of gastroenterology2016

High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.

Jens Frederik Dahlerup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.